Market Overview

A Peek Into The Market Before The Trading Starts

Share:
A Peek Into The Market Before The Trading Starts
Related AMAT
NASDAQ Says AMAT Issue Relates To Top Of PHLX Orders (TOPO) Data Feed, NASDAQ PHLX Advises Firms To Ignore AMAT On TOPO For Remainder Of Day
Citi Comments On KLA-Tencor; Applied Materials No. 1 Pick
ModernGraham Quarterly Valuation Of Applied Materials (Seeking Alpha)
Related BMY
Tuesday Morning Movers: Microsoft, Procter & Gamble Tumble Following Earnings
UPDATE: Bristol-Meyers Squibb Posts Upbeat Q4 Results, Issues Downbeat Forecast
Foreign Currency Headwinds Take The Spotlight In Drug Maker Earnings (Seeking Alpha)

Pre-open movers US stock futures are higher this morning. Futures for the Dow Jones Industrial Average surged 80 points to 15,218.00 and S&P 500 index futures rose 9.60 points to 1,636.70. Nasdaq 100 futures gained 14 points to 2,977.50.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index gained 0.55%, London's FTSE 100 index gained 0.21%, French CAC 40 Index rose 0.43% and German DAX 30 index rose 0.08%.

Asian markets ended lower, with Japan's Nikkei Stock Average falling 0.21% and Australia's ASX/S&P500 dropping 0.69%. India's Sensex tumbled 0.53%.

Broker Recommendation Analysts at Citigroup upgraded Applied Materials (NASDAQ: AMAT) from “neutral” to “buy.” The target price for Applied Materials has been raised from $14 to $20.

Applied Materials shares closed at $15.19 yesterday.

Breaking news

  • Bristol-Myers Squibb Company (NYSE: BMY) today announced the results of year two data from AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naïve rheumatoid arthritis (RA) Subjects With Background Methotrexate), a first-of-its-kind trial of 646 patients comparing the subcutaneous (SC) formulation of ORENCIA® (abatacept) vs. Humira® (adalimumab), each on a background of MTX, in biologic naïve patients with moderate to severe RA. To read the full news, click here.
  • Gigamon (NYSE: GIMO) announced today the pricing of its initial public offering of 6,750,000 shares of its common stock at a price to the public of $19.00 per share. To read the full news, click here.
  • Portland General Electric Company (NYSE: POR) announced today the pricing of a public offering of 11.1 million shares of its common stock at $29.50 per share. To read the full news, click here.
  • Cyber-security expert Avira Technologies (NYSE: AVG) announced today that Travis Witteveen has been promoted to CEO of the company, effective July 1, 2013. To read the full news, click here.

Posted-In: Citigroup US Stock FuturesNews Futures Global Pre-Market Outlook Markets

 

Related Articles (AMAT + AVG)

Around the Web, We're Loving...

Get Benzinga's Newsletters